Verastem, Inc.

VSTM ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011
Assets
Cash & Equivalents $82.2M $32.3M $24.9M $33.9M $18.9M $10.1M $33.9M
Accounts Receivable — — — — — — —
Inventory — — — — — — —
Total Current Assets $87.8M $81.3M $110.8M $95.3M $102.0M $57.1M $47.9M
Property, Plant & Equipment $861.0K $1.4M $2.0M $2.8M $631.0K $811.0K $709.0K
Goodwill — — — — — — —
Intangible Assets (Excl. Goodwill) — — — — — — —
Total Assets $89.8M $83.6M $113.1M $98.6M $125.3M $92.9M $59.0M
Liabilities
Accounts Payable $9.2M $4.1M $3.9M $3.2M $2.8M $1.8M $2.3M
Total Current Liabilities $17.1M $11.0M $10.1M $9.2M $7.8M $2.4M $3.1M
Long-Term Debt $14.8M — — — — — —
Total Liabilities $32.1M $11.3M $10.6M $9.9M $7.8M $2.5M $71.8M
Stockholders' Equity
Retained Earnings $-303.1M $-235.3M $-198.9M $-141.0M $-87.7M $-46.5M $-14.5M
Total Stockholders' Equity $57.7M $72.3M $102.5M $88.8M $117.4M $90.5M $-12.8M
← Newer Page 2 of 2 Older →